Chemical formula: C₂₄H₃₀O₃ Molecular mass: 366.493 g/mol PubChem compound: 68873
Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03D | Progestogens | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system |
Drospirenone is an active ingredient of these brands:
Austria (AT)
Brazil (BR)
Canada (CA)Croatia (HR)
Cyprus (CY)
Ecuador (EC)
Estonia (EE)
Finland (FI)
France (FR)
Hong Kong (HK)Ireland (IE)
Israel (IL)Italy (IT)
Lithuania (LT)
Malta (MT)
Netherlands (NL)Poland (PL)
Romania (RO)Singapore (SG)South Africa (ZA)
Spain (ES)
Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
